"For the nine months ended 3/31/99, net sales rose 37% to $66.6 million. Net income rose 12% to $11.6 million. Revenues reflect the acquisition of Genzyme's research products business and increased sales of R&D Systems' cytokines, antibodies and immunoassay kits. From the Techne profile on Yahoo
biz.yahoo.com
"For the three months ended June 30, 1999,...R&D Systems' Biotechnology Division net sales increased 42% to $14,963,227 from $10,539,116 and R&D Europe's net sales increased 24% to $5,819,845 from $4,705,990. R&D Systems' Hematology Division net sales also increased 6% to $3,529,119 from $3,337,860."
"For the twelve months ended June 30, 1999, ...R&D Systems' Biotechnology Division net sales increased 46% to $54,960,816 from $37,713,747 and R&D Europe's net sales increased 31% to $23,266,337 from $17,793,598. R&D Systems' Hematology Division net sales also increased 8% to $12,673,544 from $11,784,093."
biz.yahoo.com |
